openPR Logo
Press release

Human Insulin Market 2026 Industry Size, Growth Factor, Share, Trends and Global Top key Companies | Wockhardt Hospitals Ltd and Company, Boston Scientific Corporation, Sanofi and More

03-31-2020 09:49 AM CET | Health & Medicine

Press release from: Fortune Business Insights Private Limited

Human Insulin Market

Human Insulin Market

The global human insulin market size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around 425 million people across the world suffer from diabetes. This shows that the rising prevalence of diabetes is propelling growth in the market. Fortune Business Insights in a new report, titled "Human Insulin Market Size, Share & Industry Analysis, By Type (Analogue Insulin (Long-Acting, Fast Acting, Premix), Traditional Human Insulin (Long-Acting, Short-Acting, Fast Acting, Premix)), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Regional Forecast, 2019-2026" predicts the market to exhibit a CAGR of 3.4% during the forecast period. In 2018, the market value stood at USD 21.26 billion in 2018. The adoption of delivery devices primarily for insulin administration is increasing, thus driving the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-insulin-market-100395

Leading Players operating in the Human Insulin Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Novo Nordisk A/S
o Eli Lilly and Company
o Boston Scientific Corporation
o Sanofi
o Boehringer Ingelheim International GmbH
o Biocon
o Tonghua Dongbao Pharmaceutical
o Julphar
o Wockhard
o Other prominent players

Eli Lilly & Company to Launch Analogue Humalog Insulin in the U.S.

Among products, analogue insulin covered the maximum part in the human insulin market share in 2018. Analogue insulin helps to control blood sugar levels in people suffering from type 1 and type 2 diabetes. Driven by this, the adoption of analogue insulin is increasing, which increases the human insulin market size. This, coupled with the recent launch of generic insulin, is expected to contribute to the growth of the market. For instance, Eli Lilly and Company announced the launch of a generic version of analogue Humalog insulin called Insulin Lispro in April 2019. Owing to the cheaper rates of Humalog, this insulin is more accessible to diabetic patients in the country. This segment is expected to drive the human insulin market in the foreseeable future.

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Key Insights
o Prevalence of Diabetes - Key Countries
o Pipeline Analysis
o Brand Analysis
o Key Market Strategies of Leading Players
o Overview of Regulatory Scenario - Key Countries
o Global Human Insulin Market Analysis, Insights and Forecast, 2015-2026
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Type
? Analogue Insulin
o Long-acting
o Fast-acting
o Premix
? Traditional Human Insulin
o Long-acting
o Short-acting
o Fast-acting
o Premix
o Market Analysis, Insights and Forecast - By Diabetes Type
? Diabetes Type 1
? Diabetes Type 2
o Market Analysis, Insights and Forecast - By Distribution Channel
? Retail Pharmacies
? Hospital Pharmacies
? Online Pharmacies
o Market Analysis, Insights and Forecast - By Region
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa

Human Insulin Market Segmentation:

By Type
o Analogue Insulin
o Long-acting
o Fast-acting
o Premix
o Traditional Human Insulin
o Long-acting
o Short-acting
o Fast-acting
o Premix
By Diabetes Type
o Diabetes Type 1
o Diabetes Type 2
By Distribution Channel
o Retail Pharmacies
o Hospital Pharmacies
o Online Pharmacies
By Geography
o North America (U.S. and Canada)
o Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
o Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
o Latin America (Brazil, Mexico, and Rest of Latin America)
o Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Reasons to Purchase this Report:

o Comprehensive analysis of the Human Insulin Market growth drivers, obstacles, opportunities, and other related challenges.
o Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
o Identifies market restraints and boosters.
o Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/human-insulin-market-100395

KEY QUESTIONS ANSWERED:

o What are the key technological and Human Insulin Market trends shaping the market?
o What are the key opportunities in the market?
o What are the key companies operating in the market?
o Which company accounted for the highest market share?
o Why Choose Fortune Business Insights?
o What is the market size and growth rate of the global and regional market by various segments?
o What is the market size and growth rate of the market for selective countries?
o Which region or sub-segment is expected to drive the market in the forecast period?
o What Factors are estimated to drive and restrain the Human Insulin Market growth?

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Insulin Market 2026 Industry Size, Growth Factor, Share, Trends and Global Top key Companies | Wockhardt Hospitals Ltd and Company, Boston Scientific Corporation, Sanofi and More here

News-ID: 1992048 • Views:

More Releases from Fortune Business Insights Private Limited

Electro-Optical/Infrared Systems Market Will Witness A Demand Increase, Led By The Industry's Size And Key Players
Electro-Optical/Infrared Systems Market Will Witness A Demand Increase, Led By T …
The global electro-optical/infrared (EO/IR) systems market size is expected to reach USD 20.36 billion by 2026, exhibiting a CAGR of 5.84% during the forecast period. The growing necessity to improve target identification, assess threats, and monitoring in different weather conditions will spur opportunities for the market during the forecast period. The increasing application of EO/IR in fire control system, airborne homeland security, search and rescue, surveillance, and intelligence, surveillance, target
Cryogenic Equipment Market 2022 In-depth Research with Emerging Growth Trends, Regional Status of Top Key Players, and Industry Size Forecast to 2028
Cryogenic Equipment Market 2022 In-depth Research with Emerging Growth Trends, R …
This research study can be used by all participants in the Cryogenic Equipment Market as it covers all major and minor aspects of the current and future market competition. It can also prove very beneficial for stakeholders in view of the range of courses on offer and a detailed analysis of the expected growth strategies of the players in the coming years. According to the data by Ecotricity, crude oil
Natural Zeolites Market Trends, Top Key Players, Business Opportunities, Industry Share, Size Analysis by Forecast 2029
Natural Zeolites Market Trends, Top Key Players, Business Opportunities, Industr …
The global natural zeolites market size is expected to gain momentum owing to the rising demand from construction industry during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Natural Zeolites Market, 2022-2029." They are aluminosilicate minerals with a microporous surface that allows them to absorb a wide range of cations, including water. They are mined using traditional open-pit mining processes and they
Lemon Oil Market Share, Demand, Top Players, Industry Size, Future Growth By 2029
Lemon Oil Market Share, Demand, Top Players, Industry Size, Future Growth By 202 …
The global lemon oil market size is expected to gain momentum owing to the rising demand in cosmetic & personal care during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Lemon Oil Market, 2022-2029." Liquid sunshine is another name for lemon oil. It's a citrus essential oil with a fresh scent that comes from the citrus lemon plant. The oil is extracted

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Bluetooth connected smart insulin pens represent the future of insulin delivery …
Increasing pool of diabetic patients witnessed across the globe has prompted leading manufacturers of medical devices towards development of ground-breaking products. Smart insulin pens are among such devices that have revolutionised the global market for diabetic injection pens. A recent study published by Future Market Insights projects that the global smart insulin pens market, which is currently valued at US$ 0.86 Mn, will expand vigorously at 17.9% CAGR through the
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin
Insulin Drug and Delivery Technologies Market Report 2018: Segmentation by Produ …
Global Insulin Drug and Delivery Technologies market research report provides company profile for Julphar, Ypsomed, Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
09-06-2017 | Health & Medicine
MRRSE
Smart Insulin Pens Market: Bluetooth Connected Smart Insulin Pens Allow Effectiv …
By connectivity, the Bluetooth connected smart insulin pen segment is expected to account for a value share of US$ 0.276 Mn in 2017. The segment is expected to reach a little more than US$ 2 Mn by 2027 end, registering the highest CAGR of 23.2% over the forecast period. Bluetooth connected smart insulin pens represent the future of insulin delivery devices. Such devices have an inbuilt Bluetooth connectivity feature allowing
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact